Andreeva L I, Khavinson V Kh
Biull Eksp Biol Med. 1993 Sep;116(9):233-5.
The study has shown the efficiency of heart peptide preparation (HP) in the management of rubomycin cardiomyopathy. HP does not prevent rat mortality if rubomycin doses are very large, but it can improve a state of survived animals. HP affects restoration processes in myocardium improving the myocardial contractibility.
该研究表明了心脏肽制剂(HP)在柔红霉素心肌病治疗中的有效性。如果柔红霉素剂量非常大,HP并不能防止大鼠死亡,但它可以改善存活动物的状态。HP影响心肌的恢复过程,提高心肌收缩性。